🟢 IYH is trading 5.3% up today on generic drug tariff plans and GSK FDA approval

IYH is trading 5.3% up today as healthcare stocks rally in response to shifting U.S. drug policies and key regulatory milestones.

• Sentiment is being driven by Trump administration plans to impose steep tariffs on imported generic pharmaceuticals, which is expected to benefit U.S.-based and branded drug manufacturers.
• The FDA's approval of GSK’s oncology drug Jideytro has provided an additional catalyst for the sector's pre-market surge.
• The move is notably sector-specific, as broader equity futures are only seeing modest gains compared to the sharp rise in healthcare-related assets.